Evidence map›Paper›PMID 31781743›Full record

ArticleAmerican journal of epidemiology2020

Risk Prediction Models for Head and Neck Cancer in the US Population From the INHANCE Consortium.

Yuan-Chin Amy Lee, Mohammed Al-Temimi, Jian Ying, Joshua Muscat, Andrew F Olshan, Jose P Zevallos, Deborah M Winn, Guojun Li, Erich M Sturgis, Hal Morgenstern and 17 more

Abstract readValidation Study
In one paragraph

Article in American journal of epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Genetic susceptibility, risk prediction, and druggable targets for oropharyngeal cancer: a UK Biobank study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  3. Oral cancer large observational screening study in Hungary.European journal of public health · 2026
    Observational
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Risk prediction models for head and neck cancer: A rapid review.Laryngoscope investigative otolaryngology · 2022
    Review
  11. Article
  12. Review
  13. Oral Cancer Screening: Past, Present, and Future.Journal of dental research · 2021
    Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Yuan-Chin Amy Lee
Mohammed Al-Temimi
Jian Ying
Joshua Muscat
Andrew F Olshan
Jose P Zevallos
Deborah M Winn
Guojun Li
Erich M Sturgis
Hal Morgenstern
Zuo-Feng Zhang
Elaine Smith
Karl Kelsey
Michael McClean
Thomas L Vaughan
Philip Lazarus
Chu Chen
Stephen M Schwartz
Maura Gillison
Stimson Schantz
Guo-Pei Yu
Gypsyamber D'Souza
Neil Gross
Marcus Monroe
Jaewhan Kim
Paolo Boffetta
Mia Hashibe

Funding

UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
UCLA SPORE IN LUNG CANCERP50CA090388 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2001 to 2008
$13.0M
UDP GLUCURONOSYLTRANSFERASES, DETOXIFICATION OF NNKP01CA068384 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI LAZARUS, PHILIP · 1995 to 2005
$8.5M
UCLA CANCER EPIDEMIOLOGY TRAINING PROGRAMT32CA009142 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZHANG, ZUO-FENG · 1986 to 2024
$6.3M
Molecular Epidemiology of Head and Neck CancerR01ES011740 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WEI, QINGYI · 2001 to 2012
$6.3M
The Boston Collaborative Oral Cancer StudyR01CA078609 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI KELSEY, KARL TIMOTHY · 1999 to 2010
$5.3M
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERSU01CA096134 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MAO, JENNY T · 2002 to 2007
$5.1M
Gene Environment Interaction in Head and Neck CancerR01CA090731 · NCI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI OLSHAN, ANDREW · 2001 to 2005
$4.6M
UDPGLUCURONOSYLTRANSFERASE GENOTYPE AND ORAL CANCER RISKR01DE013158 · NIDCR · UNIVERSITY OF SOUTH FLORIDA · PI LAZARUS, PHILIP · 2000 to 2011
$3.6M
Patterns of Somatic Gene Alterations in Oral CancerR01CA100679 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI KELSEY, KARL TIMOTHY · 2004 to 2012
$2.6M
Oral HPV Infection in HIV-Infected Men and WomenR01DE016631 · NIDCR · OHIO STATE UNIVERSITY · PI GILLISON, MAURA L · 2005 to 2008
$2.5M
FIC NIH HHS R03 TW001500NCATS NIH HHS UL1 TR002538NCI NIH HHS K07 CA104231NCI NIH HHS P01 CA068384NCI NIH HHS P50 CA090388NCI NIH HHS R01 CA030022NCI NIH HHS R01 CA048996NCI NIH HHS R01 CA078609NCI NIH HHS R01 CA090731NCI NIH HHS R01 CA100264NCI NIH HHS R01 CA100679NCI NIH HHS R03 CA077954NCI NIH HHS R03 CA113157NCI NIH HHS R13 CA210555NCI NIH HHS R21 CA158848NCI NIH HHS T32 CA009142NCI NIH HHS U01 CA096134NIDA NIH HHS R01 DA011386NIDCR NIH HHS R01 DE013110NIDCR NIH HHS R01 DE013158NIDCR NIH HHS R01 DE016631NIDCR NIH HHS R03 DE016611NIEHS NIH HHS P30 ES010126NIEHS NIH HHS R01 ES011740NIEHS NIH HHS R21 ES011667
6 · The paper itself

Abstract

Head and neck cancer (HNC) risk prediction models based on risk factor profiles have not yet been developed. We took advantage of the large database of the International Head and Neck Cancer Epidemiology (INHANCE) Consortium, including 14 US studies from 1981-2010, to develop HNC risk prediction models. Seventy percent of the data were used to develop the risk prediction models; the remaining 30% were used to validate the models. We used competing-risk models to calculate absolute risks. The predictors included age, sex, education, race/ethnicity, alcohol drinking intensity, cigarette smoking duration and intensity, and/or family history of HNC. The 20-year absolute risk of HNC was 7.61% for a 60-year-old woman who smoked more than 20 cigarettes per day for over 20 years, consumed 3 or more alcoholic drinks per day, was a high school graduate, had a family history of HNC, and was non-Hispanic white. The 20-year risk for men with a similar profile was 6.85%. The absolute risks of oropharyngeal and hypopharyngeal cancers were generally lower than those of oral cavity and laryngeal cancers. Statistics for the area under the receiver operating characteristic curve (AUC) were 0.70 or higher, except for oropharyngeal cancer in men. This HNC risk prediction model may be useful in promoting healthier behaviors such as smoking cessation or in aiding persons with a family history of HNC to evaluate their risks.

Indexed as

Models, TheoreticalAgedCase-Control StudiesFemaleHead and Neck NeoplasmsHumansMaleMiddle AgedRisk AssessmentUnited Statesabsolute riskhead and neck cancerhypopharyngeal cancerlaryngeal canceroral cavity canceroropharyngeal cancerrisk prediction

Identifiers

PMID31781743
PMCPMC7274188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.